排序方式: 共有7条查询结果,搜索用时 15 毫秒
1
1.
描述了产自广西木兰科一新种:靖西长喙木兰(Lirianthe jingxiensis Y. H. Tong&N. H. Xia)。本种形态上与绢毛木兰[L. albosericea(Chun&C. H. Tsoong)N. H. Xia&C. Y. Wu]接近,但区别在于该种植株较矮,幼枝、叶柄和幼叶被黄棕色绢毛,叶柄较宽,叶片较宽,倒卵形或倒卵状椭圆形,先端钝或短渐尖,花被片较大,心皮数目较多,被黄棕色绢毛。 相似文献
2.
Wang Y Bian F Deng S Shi Q Ge M Wang S Zhang X Xu S 《Journal of biomolecular structure & dynamics》2011,28(6):881-893
Poly(ADP-ribose) polymerase (PARP) is regarded as a target protein for paclitaxel (PTX) to bind. An important issue is to identify the key residues as active sites for PTX interacting with PARP, which will help to understand the potential drug activity of PTX against cancer cells. Using docking method and MD simulation, we have constructed a refined structure of PTX docked on the catalytic function domain of PARP (PDB code: 1A26). The residues Glu327(988), Tyr246(907), Lys242(903), His165(826), Asp105(766), Gln102(763) and Gln98(759) in PARP are identified as potential sites involved in interaction with PTX according to binding energy (E(b)) between PTX and single residue calculated with B3LYP/6-31G(d,p). These residues form an active binding pocket located on the surface of the catalytic fragment, possibly interacting with the required groups of PTX leading to its activity against cancer cells. It is noted that most of the active sites make conatct with the "southern hemisphere" of PTX except for one residue, Tyr246(907), which interacts with the "northern hemisphere" of PTX. The conformation of PTX in complex with the catalytic fragment is observed as being T-shaped, similar to that complexed with β-tubulin. The total Eb of -269.9 kJ/mol represents the potent interaction between PTX and the catalytic fragment, implying that PTX can readily bind to the active pocket. The tight association of PTX with the catalytic fragment would inhibit PARP activation, suggesting a potential application of PTX as an effective antineoplastic agent. 相似文献
3.
4.
Xingkang Wu Zhenyu Li Yuemao Shen 《Biochimica et Biophysica Acta (BBA)/General Subjects》2018,1862(5):1134-1147
Background
Mitosis, the most dramatic event in the cell cycle, involves the reorganization of virtually all cellular components. Antimitotic agents are useful for dissecting the mechanism of this reorganization. Previously, we found that the small molecule CS1 accumulates cells in G2/M phase [1], but the mechanism of its action remains unknown.Methods
Cell cycle analysis, live cell imaging and nuclear staining were used. Chromosomal morphology was detected by chromosome spreading. The effects of CS1 on microtubules were confirmed by tubulin polymerization, colchicine tubulin-binding, cellular tubulin polymerization and immunofluorescence assays and by analysis of microtubule dynamics and molecular modeling. Histone phosphoproteomics was performed using mass spectrometry. Cell signaling cascades were analyzed using immunofluorescence, immunoprecipitation, immunoblotting, siRNA knockdown and chemical inhibition of specific proteins.Results
The small molecule CS1 was shown to be an antimitotic agent. CS1 potently inhibited microtubule polymerization via interaction with the colchicine-binding pocket of tubulin in vitro and inhibited the formation of the spindle apparatus by reducing the bulk of growing microtubules in HeLa cells, which led to activation of the spindle assembly checkpoint (SAC) and mitotic arrest of HeLa cells. Compared with colchicine, CS1 impaired the progression of sister chromatid resolution independent of cohesin dissociation, and this was reversed by the removal of CS1. Additionally, CS1 induced unique histone phosphorylation patterns distinct from those induced by colchicine.Conclusions and significance
CS1 is a unique antimitotic small molecule and a powerful tool with unprecedented value over colchicine that makes it possible to specifically and conditionally perturb mitotic progression. 相似文献5.
Shi G Wang Y Jin Y Chi S Shi Q Ge M Wang S Zhang X Xu S 《Journal of biomolecular structure & dynamics》2012,30(5):559-573
Epothilone A (EpoA) is under investigation as an antitumor agent. To provide better understanding of the activity of EpoA against cancers, by theoretical studies such as using docking method, molecular dynamics simulation and density functional theory calculations, we identify several key residues located on β-tubulin as the active sites to establish an active pocket responsible for interaction with EpoA. Eight residues (Arg276, Asp224, Asp26, His227, Glu27, Glu22, Thr274, and Met363) are identified as the active sites to form the active pocket on β-tubulin. The interaction energy is predicted to be -121.3?kJ/mol between EpoA and β-tubulin. In the mutant of β-tubulin at Thr274Ile, three residues (Arg359, Glu27, and His227) are identified as the active sites for the binding of EpoA. In the mutant of β-tubulin at Arg282Gln, three residues (Arg276, Lys19, and His227) serve as the active sites. The interaction energy is reduced to -77.2?kJ/mol between EpoA and Arg282Gln mutant and to -50.2?kJ/mol between EpoA and Thr274Ile mutant. The strong interaction with β-tubulin is significant to EpoA's activity against cancer cells. When β-tubulin is mutated either at Arg282Gln or at Thr274Ile, the decreased strength of interaction explains the activity reduced for EpoA. Therefore, this work shows that the structural basis of the active pocket plays an important role in regulating the activity for EpoA with a Taxol-like mechanism of action to be promoted as an antitumor agent. 相似文献
6.
Paclitaxel (PTX) is used to treat various cancers, but it also causes serious side effects and resistance. To better design
similar compounds with less toxicity and more activity against drug-resistant tumors, it is important to clearly understand
the PTX-binding pocket formed by the key residues of active sites on β-tubulin. Using a docking method, molecular dynamics
(MD) simulation and density functional theory (DFT), we identified some residues (such as Arg278, Asp26, Asp226, Glu22, Glu27,
His229, Arg369, Lys218, Ser277 and Thr276) on β-tubulin that are the active sites responsible for interaction with PTX. Another
two residues, Leu371 and Gly279, also likely serve as active sites. Most of these sites contact with the “southern hemisphere”
of PTX; only one key residue interacts with the “northern hemisphere” of PTX. These key residues can be divided into four
groups, which serve as active compositions in the formation of an active pocket for PTX binding to β-tubulin. This active
binding pocket enables a very strong interaction (the strength is predicted to be in the range of −327.8 to −365.7 kJ mol−1) between β-tubulin and PTX, with various orientated conformations. This strong interaction means that PTX possesses a high
level of activity against cancer cells, a result that is in good agreement with the clinical mechanism of PTX. The described
PTX pocket and key active residues will be applied to probe the mechanism of tumor cells resistant to PTX, and to design novel
analogs with superior properties. 相似文献
7.
Li Xiaomei Wu Xingkang Zhu Jing Shen Yuemao 《Applied microbiology and biotechnology》2018,102(2):689-702
Ten new pentangular polyphenols, namely amexanthomycins A–J (1–10) were isolated from the strain Amycolatopsis mediterranei S699∆rifA constructed by deleting the polyketide synthase genes responsible for the biosynthesis of rifamycins. Their structures were elucidated on the basis of 1D and 2D NMR spectroscopic data and high-resolution ESIMS. Amexanthomycins A–C (1–3) showed inhibitory activity against human DNA topoisomerases.
相似文献
1